Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 164.000 - Licensure of Substance Abuse Treatment Programs › Part TWO - REQUIREMENTS FOR SERVICE PROVISION › Section 164.305 - Provision of Services - Opioid Treatment Programs

Current through Register 1525, July 5, 2024
(A)
Central Registry
				System
.
(1) All Opioid Treatment
				Programs shall participate in the Central Registry System to expedite the
				admission process by verification of medication and dose, prevent a patient's
				simultaneous enrollment in more than one Opioid Treatment Program, facilitate
				disaster response and allow access to treatment during emergencies throughout
				the State, and ensure accurate dispensing of medication in accordance with
				state and federal laws and regulations.
(2) The Program Director and at least two
				other employees designated by the Program Director shall have access to the
				Central Registry System and be properly trained in the Central Registry
				System.
(3) Each Opioid Treatment
				Program must:
(a) Upon admission, inform all
				patients of the Opioid Treatment Program's participation in the Central
				Registry System;
(b) Prior to
				initiating a Central Registry System inquiry, obtain the patient's written
				consent;
(c) Include information
				about the Central Registry System in the Client Handbook and as part of patient
				orientations;
(d) Ensure evidence
				of the written consent and orientation is included in the patient's medical
				record;
(e) Initiate a clearance
				inquiry to the Central Registry System by submitting all information required
				by the State Opioid Treatment Authority prior to admitting a patient to the
				Opioid Treatment Program;
(f)
				Verify with the Central Registry System that the prospective patient is not
				presently enrolled in another Opioid Treatment Program, and document this
				verification in the patient's record;
(g) Report any other information required by
				the Department; and
(h) Report all
				admissions, transfers, and discharges, and any other required information as
				soon as possible, but not more than 72 hours later into to the Central Registry
				System.
(4) No person who
				is reported by the Central Registry System to be participating in another
				Opioid Treatment Program shall be admitted to an Opioid Treatment Program. In
				the event a dual enrollment is found by either Opioid Treatment Program in
				which the patient is participating, the patient shall be discharged from one
				Opioid Treatment Program in order to continue enrollment at another Opioid
				Treatment Program.
(5) The Opioid
				Treatment Program shall notify the State Opioid Treatment Authority within 24
				hours of any patient who is found by an Opioid Treatment Program to be
				simultaneously enrolled in another Opioid Treatment Program.
(6) Information made available by the Central
				Registry System to Opioid Treatment Programs as approved by the State Opioid
				Treatment Authority shall also be treated as confidential in accordance with
				all state and federal regulations including, but not limited to, 42 CFR Part 2
				and shall not be shared with others, including state or federal agencies,
				unless permitted by confidentiality laws and regulations.
(7) Opioid Treatment Programs shall not
				disclose any information to a treating provider that is a non-member of the
				Central Registry System regardless of whether there is a treating provider
				relationship, unless there is a patient specific authorized consent which
				complies with 42 CFR Part 2.
(8)
				The Opioid Treatment Program shall develop policies and procedures for:
(a) Orienting patients and staff to the
				Central Registry System; and
(b)
				Training for staff to ensure compliance with 105 CMR 164.305(A). Evidence of
				this training shall be documented in staff's personnel files.
(9)
All Hazard and
				Emergency Planning and Procedures plan
. Opioid Treatment Programs
				shall include use of the Central Registry System to ensure patient access to
				care, accuracy and efficiency in dosing services during an emergency by
				ensuring medication dosing information can be shared between licensed and/or
				certified Opioid Treatment Programs and the State Opioid Treatment Authority
				and/or their delegate.